Boston Scientific today announced that is has entered an agreement to acquire Devoro Medical for more than $269 million.
Marlborough, Massachusetts-based Boston Scientific has been a strategic investor in Devoro Medical since 2019, according to the company. It has an equity stake of approximately 16%. The transaction will consist of an upfront payment of approximately $269 million for the 84% stake that is not owned and up to $67 million upon achievement of certain clinical and regulatory milestones.
Get the full story on our sister site, Medical Tubing + Extrusion.